Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs Microchip Technology Inc. (MCHP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs Microchip Technology Inc. — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.5 (market cap $31.07B), while Microchip Technology Inc. trades at $70.12 (market cap $40.27B). The key difference: Microchip Technology Inc. is the larger of the two by market cap, and Microchip Technology Inc. pays the higher dividend (2.45%). Which is the better fit depends on your goals.
| GEHC | MCHP | |
|---|---|---|
Market Cap | $31.07B | $40.27B |
Volume | 3,443,020 | 6,570,711 |
Sector | Health | Technology |
52-Week High | $88.16 | $102.97 |
52-Week Low | $59.48 | $49.02 |
Enterprise Value | $39.53B | $45.40B |
Dividend Yield | 0.23% | 2.45% |
Typical Hold Time | — | 63 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
Microchip Technology (MCHP) trades at $71.25, down 3.49% today, with a bearish technical signal from moving averages. The company shows mixed fundamentals with strong recent earnings beats but negative net income in 2025. Recent developments include the acquisition of Hailo and expansion of Ethernet and power portfolios targeting automotive and data center markets. Analyst consensus remains strongly bullish with a $110.50 price target despite current weakness.
MCHP faces near-term headwinds from cyclical semiconductor demand but maintains long-term growth potential through AI infrastructure and automotive connectivity. High valuation ratios (P/E 109.06) and significant debt ($5.63B) present risks, while institutional accumulation and product expansion provide upside catalysts. The stock offers 55% upside to consensus target if execution improves.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About Microchip Technology Inc.
Microchip became an independent company in 1989 when it was spun off from General Instrument. More than half of revenue comes from MCUs, which are used in a wide array of electronic devices from remote controls to garage door openers to power windows in autos. The company's strength lies in lower-end 8-bit MCUs that are suitable for a wider range of less technologically advanced devices, but the firm has expanded its presence in higher-end MCUs and analog chips as well.
Read more on MCHP →
